Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epilepsy and the immune system.

J A Aarli1

  • 1Department of Neurology, University of Bergen, Haukeland Hospital, Jonas Lies v 65, 5021 Bergen, Norway. johan.a.aarli@haukeland.no

Archives of Neurology
|December 15, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Titin antibody positive myasthenia gravis patients have a cellular immune response against the main immunogenic region of titin.

European journal of neurology·2013
Same author

Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features.

European journal of neurology·2007
Same author

Post-polio syndrome patients treated with intravenous immunoglobulin: a double-blinded randomized controlled pilot study.

European journal of neurology·2007
Same author

Titin and ryanodine receptor antibodies in myasthenia gravis.

Acta neurologica Scandinavica. Supplementum·2006
Same author

Myasthenia gravis: disease severity and prognosis.

Acta neurologica Scandinavica. Supplementum·2006
Same author

Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis.

Neurology·2006
Same journal

Incorrect Table Entries and Word.

Archives of neurology·2016
Same journal

IDEAL for CCSVI Research-Reply.

Archives of neurology·2013
Same journal

Atlas of Inherited Metabolic Diseases, 3rd ed.

Archives of neurology·2013
Same journal

Error in byline: in heterogeneity of coenzyme q10 deficiency: patient study and literature review.

Archives of neurology·2013
Same journal

This month in archives of neurology.

Archives of neurology·2013
Same journal

About this journal.

Archives of neurology·2013
See all related articles

Evidence suggests immune mechanisms contribute to epilepsy. Rasmussen encephalitis, an autoimmune disorder, involves antibodies to glutamate receptor GluR3, offering potential new treatments for some epilepsy cases.

Area of Science:

  • Neuroimmunology
  • Epileptology

Background:

  • Immune system disorders are increasingly recognized in neurological conditions.
  • Understanding the immune basis of epilepsy is crucial for developing novel therapies.

Purpose of the Study:

  • To review evidence linking immune mechanisms to epilepsy pathogenesis.
  • To explore potential autoimmune targets in epilepsy treatment.

Main Methods:

  • Comprehensive literature review of published reports.
  • Analysis of studies on immune system disorders in human and experimental epilepsy.

Main Results:

  • Rasmussen encephalitis exemplifies an autoimmune CNS disorder, with antibodies to glutamate receptor GluR3 implicated.
  • Antiphospholipid antibodies in systemic lupus erythematosus may contribute to immune-mediated cortical damage in epilepsy.

Related Experiment Videos

  • Immune defects in epilepsy may stem from antiepileptic drug treatment or genetic factors.

    • Conclusions:

    • Identifying an immunological basis for epilepsy opens new therapeutic avenues.
    • Targeting immune mechanisms may offer treatment options for intractable partial epilepsies.